Driving research, providing support and improving outcomes for patients and their families affected by rare conditions

The 7th Birt-Hogg-Dubé (BHD) International Symposium convened virtually in October 2021. The meeting attracted more than 200 participants internationally and highlighted recent findings in a variety of areas, including genetic insight and molecular understanding of BHD syndrome, structure and function of the tumor suppressor Folliculin (FLCN), therapeutic and clinical advances as well as patients’ experiences living with this malady.

It was our absolute pleasure to bring the BHD community together for an inclusive and inspiring meeting, and we look forward to further interaction and collaboration.

The conference report has now been published in OncoAlert. Please read the report to find details of the scientific and clinical advances discussed.